Theoretical Investigation of 1-(4-Fluorophenyl)-3-(4-methylphenyl)triazene: DFT Analysis, NLO Properties, Chemical Reactivity, Hirshfeld Surface Analysis, and Molecular Docking

Öz

1-(4-Fluorophenyl)-3-(4-methylphenyl)triazene (I) has been studied using an in-depth theoretical approach that combines density functional theory (DFT), Hirshfeld surface analysis (HSA), and molecular docking (MD). Complete geometry optimization was performed at the B3LYP/6-311++G(d,p) level, showing excellent agreement with experimental X-ray crystallography data (RMSD = 0.135 Å). The results confirm the reliability of the computational approach. The compound has an almost flat structure with conjugated π-electron systems, making it easier to delocalize the electrons. This is responsible for the optical properties. From the results, it is clear that the compound has good nonlinear optical (NLO) properties. The total dipole moment is 1.6673 D, and the first-order hyperpolarizability (βtot) is 9.0072 × 10-30 e.s.u. Frontier molecular orbital (FMO) analysis shows that the HOMO-LUMO energy difference is approximately 3.8 eV, showing that it is not very reactive. From the molecular electrostatic potential (MEP) surface, it is clear that the compound I has nucleophilic sites at the nitrogen and fluorine atoms. From the thermo-dynamic properties, it is clear that the heat capacity, entropy, and enthalpy increase with increasing temperature. From the HSA, it is clear that the compound I is held together by H···H (48.6%) and C···H/H···C (19.4%). Hydrogen bonds play an important role in the secondary interactions. MD of the compound I against the HER2 receptor showed a binding affinity of -9.3 kcal·mol-1, mainly through hydrophobic interactions with Met774, Leu785, Phe864, and Leu796. These results highlight the potential of the compound as a small molecule HER2 receptor antagonist. These results provide a better understanding of the electronic, structural, optical, and pharmacological properties of the compound I and establish the importance of the compound in optoelectronic and drug development fields.

Anahtar Kelimeler

• Triazene
• DFT
• NLO properties
• HOMO–LUMO
• Hirshfeld surface analysis
• HER2 docking

Kaynakça

1. P. de M. S. Figueirêdo, J. C. S. Filho, A. de J. S. Sodré, J. R. de Castro Júnior, I. S. Gonçalves, R. V. Blasques, et al., “Assessment of the biological potential of diaryltriazene-derived triazene compounds,” Scientific Reports, vol. 11, Art. no. 2541, 2021, doi: 10.1038/s41598-021-81823-2.
2. S. Lamichhane, R. P. Rai, A. Khatri, R. Adhikari, B. G. Shrestha, and S. K. Shrestha, “Screening of phytochemicals as potential anti-breast cancer agents targeting HER2: An in-silico approach,” J. Biomol. Struct. Dyn., vol. 41, no. 3, pp. 897-911, 2023, doi: 10.1080/07391102.2021.2014972.
3. R. B. O. Ouma, S. M. Ngari, and J. K. Kibet, “A review of the current trends in computational approaches in drug design and metabolism,” Discover Public Health, vol. 21, Art. no. 108, 2024, doi: 10.1186/s12982-024-00229-3.
4. M. J. Frisch et al., Gaussian 03, Revision C.02. Wallingford, CT, USA: Gaussian Inc., 2004.
5. C. Lee, W. Yang, and R. G. Parr, “Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density,” Phys. Rev. B, vol. 37, no. 2, pp. 785-789, 1988, doi: 10.1103/PhysRevB.37.785.
6. A. D. Becke, “Density-functional thermochemistry. III. The role of exact exchange,” J. Chem. Phys., vol. 98, no. 7, pp. 5648-5652, 1993, doi: 10.1063/1.464913.
7. R. Dennington, T. Keith, and J. Millam, GaussView, Version 4.1.2. Shawnee Mission, KS, USA: Semichem Inc., 2007.
8. R. G. Parr, L. V. Szentpály, and S. Liu, “Electrophilicity index,” J. Am. Chem. Soc., vol. 121, no. 9, pp. 1922-1924, 1999, doi: 10.1021/ja983494x.

9. J. Tomasi, B. Mennucci, and R. Cammi, “Quantum mechanical continuum solvation models,” Chem. Rev., vol. 105, no. 8, pp. 2999-3094, 2005, doi: 10.1021/cr9904009.
10. M. J. Turner, J. J. McKinnon, S. K. Wolff, D. J. Grimwood, P. R. Spackman, D. Jayatilaka, and M. A. Spackman, CrystalExplorer17 (Version 17.5). Perth, Australia: University of Western Australia, 2017.
11. J. J. McKinnon, D. Jayatilaka, and M. A. Spackman, “Towards quantitative analysis of intermolecular interactions with Hirshfeld surfaces,” Chem. Commun., no. 37, pp. 3814-3816, 2007, doi: 10.1039/B704980C.
12. M. A. Spackman and D. Jayatilaka, “Hirshfeld surface analysis,” CrystEngComm, vol. 11, no. 1, pp. 19-32, 2009, doi: 10.1039/B818330A.
13. F. L. Hirshfeld, “Bonded-atom fragments for describing molecular charge densities,” Theor. Chim. Acta, vol. 44, no. 2, pp. 129-138, 1977, doi: 10.1007/BF00549096.
14. K. Aertgeerts, R. Skene, J. Yano, B. C. Sang, H. Zou, G. Snell, A. Jennings, K. Iwamoto, N. Habuka, A. Hirokawa, T. Ishikawa, T. Tanaka, H. Miki, Y. Ohta, and S. Sogabe, “Structural analysis of the mechanism of inhibition and allosteric activation of the kinase domain of HER2 protein,” J. Biol. Chem., vol. 286, no. 21, pp. 18756-18765, 2011, doi: 10.1074/jbc.M110.206193.
15. O. Trott and A. J. Olson, “AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading,” J. Comput. Chem., vol. 31, no. 2, pp. 455-461, 2010, doi: 10.1002/jcc.21334.
16. Dassault Systèmes BIOVIA, Discovery Studio Visualizer, Version 17.2. San Diego, CA, USA: Dassault Systèmes, 2016.
17. N. Karadayı, Ş. Çakmak, M. Odabaşoğlu, and O. Büyükgüngör, “1,3-Bis(4-methylphenyl)triazene, 1-(4-chlorophenyl)-3-(4-fluorophenyl)triazene and 1-(4-fluorophenyl)-3-(4-methylphenyl)triazene,” Acta Crystallogr. Sect. E Struct. Rep. Online, vol. 61, no. 5, pp. o303-o305, 2005, doi: 10.1107/S0108270105004373.
18. A. L. Spek, “Structure validation in chemical crystallography,” Acta Crystallogr. Sect. D Biol. Crystallogr., vol. 65, no. 2, pp. 148-155, 2009, doi: 10.1107/S090744490804362X.
19. P. N. Prasad and D. J. Williams, Introduction to Nonlinear Optical Effects in Molecules and Polymers. Hoboken, NJ, USA: John Wiley & Sons, 1991, pp. 106-130.
20. D. S. Chemla and J. Zyss, Nonlinear Optical Properties of Organic Molecules and Crystals. New York, NY, USA: Academic Press, 1987.
21. D. Maliszewski and D. Drozdowska, “Recent advances in the biological activity of s-triazine core compounds,” Pharmaceuticals, vol. 15, no. 2, Art. no. 221, 2022, doi: 10.3390/ph15020221.
22. R. G. Parr and W. Yang, Density-Functional Theory of Atoms and Molecules. New York, NY, USA: Oxford University Press, 1989.
23. P. Politzer and J. S. Murray, “The fundamental nature and role of the electrostatic potential in atoms and molecules,” Theor. Chem. Acc., vol. 108, no. 3, pp. 134-142, 2002, doi: 10.1007/s00214-002-0363-9.
24. P. Geerlings, F. De Proft, and W. Langenaeker, “Conceptual density functional theory,” Chem. Rev., vol. 103, no. 5, pp. 1793-1874, 2003, doi: 10.1021/cr990029p.
25. P. K. Chattaraj, Chemical Reactivity Theory: A Density Functional View. Boca Raton, FL, USA: CRC Press, 2009, doi: 10.1201/9781420065442.
26. C. J. Cramer and D. G. Truhlar, “Implicit solvation models: Equilibria, structure, spectra, and dynamics,” Chem. Rev., vol. 99, no. 8, pp. 2161-2200, 1999, doi: 10.1021/cr960149m.
27. C. J. Cramer, Essentials of Computational Chemistry: Theories and Models, 2nd ed. Hoboken, NJ, USA: Wiley, 2004, p. 179.
28. R. S. Mulliken, “Electronic population analysis on LCAO-MO molecular wave functions. I,” J. Chem. Phys., vol. 23, no. 10, pp. 1833-1840, 1955, doi: 10.1063/1.1740588.
29. A. E. Reed, R. B. Weinstock, and F. Weinhold, “Natural population analysis,” J. Chem. Phys., vol. 83, no. 2, pp. 735-746, 1985, doi: 10.1063/1.449486.
30. R. F. W. Bader, Atoms in Molecules: A Quantum Theory. Oxford, U.K.: Oxford University Press, 1990.
31. D. A. McQuarrie, Statistical Mechanics. Sausalito, CA, USA: University Science Books, 2000, p. 55.
32. P. Atkins, J. de Paula, and J. Keeler, Atkins’ Physical Chemistry, 11th ed. Oxford, U.K.: Oxford University Press, 2017.
33. J. J. McKinnon, M. A. Spackman, and A. S. Mitchell, “Novel tools for visualizing and exploring intermolecular interactions in molecular crystals,” Acta Crystallogr. Sect. B Struct. Sci., vol. 60, no. 5, pp. 627-668, 2004, doi: 10.1107/S0108768104020300.
34. D. B. Kitchen, H. Decornez, J. R. Furr, and J. Bajorath, “Docking and scoring in virtual screening for drug discovery: Methods and applications,” Nat. Rev. Drug Discov., vol. 3, no. 11, pp. 935-949, 2004, doi: 10.1038/nrd1549.
35. Z. Liu, Y. Li, L. Han, J. Li, J. Liu, Z. Zhao, W. Nie, Y. Liu, and R. Wang, “PDB-wide collection of binding data: Current status of the PDBbind database,” Bioinformatics, vol. 31, no. 3, pp. 405-412, 2015, doi: 10.1093/bioinformatics/btu626.
36. G. L. Warren, C. W. Andrews, A. M. Capelli, B. Clarke, J. LaLonde, M. H. Lambert, M. Lindvall, N. Nevins, S. F. Semus, S. Senger, G. Tedesco, I. D. Wall, J. M. Woolven, C. E. Peishoff, and M. S. Head, “A critical assessment of docking programs and scoring functions,” J. Med. Chem., vol. 49, no. 20, pp. 5912-5931, 2006, doi: 10.1021/jm050362n.
37. H. N. Yoğurtçu and C. C. Ersanlı, “Structural parameters, NLO, HOMO, LUMO, MEP, chemical reactivity descriptors, Mulliken-NPA, thermodynamic functions, Hirshfeld surface analysis and molecular docking of 1,3-bis(4-methylphenyl)triazine,” Int. Sci. Vocat. Stud. J., vol. 9, no. 1, pp. 130-144, 2025, doi: 10.47897/bilmes.1697802.
38. C. C. Ersanlı and S. Başak, “A multidimensional investigation from electronic properties to biological activity of 2-[(4-hydroxyphenyl)iminomethyl]thiophene by DFT, HOMO-LUMO, MEP, NLO, NBO, Mulliken, Hirshfeld and molecular docking analyses,” Int. Sci. Vocat. Stud. J., vol. 9, no. 1, pp. 145-160, 2025, doi: 10.47897/bilmes.1704235.
39. N. S. Pagadala, K. Syed, and J. Tuszynski, “Software for molecular docking: A review,” Biophys. Rev., vol. 9, no. 2, pp. 91-102, 2017, doi: 10.1007/s12551-016-0247-1.
40. S. Genheden and U. Ryde, “The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities,” Expert Opin. Drug Discov., vol. 10, no. 5, pp. 449-461, 2015, doi: 10.1517/17460441.2015.1032936.